On Thursday, MedPAC concluded that even though doctors’ pay hasn’t kept up with ...
Chronic fatigue syndrome is clearly "is not a rare illness,” said the CDC's Eliz...
STAT spoke to the CEO of CRISPR Therapeutics about how the company secured a his...
What a sickle cell disease patient thinks is the biggest challenge facing a newl...
The FDA has approved the world’s first medicine based on CRISPR gene-editing tec...
Understand how science, health policy, and medicine shape the world everyday. Si...
Want to stay on top of the science and politics driving biotech today? Sign up t...
Biden's plan to sidestep certain patents is causing uncertainty over the extent ...
Ethical AI guardrails are imperative for health care’s future. A new version of ...
"Despite a general meaningful aspiration to remain focused on the patient and th...
Universities and research institutions comment that the U.S. Office of Research ...
Senators are pushing the Biden administration to collect more data on #MedicareA...
News of the FDA's historic approval of the first gene therapies for sickle cell ...
Pfizer’s Elrexfio for treating multiple myeloma has been granted conditional ma...
The combination therapy of MSD’s Keytruda (pembrolizumab) and Eisai’s Lenvima (...
Kymera Therapeutics has dosed the first patient in the Phase II ADVANTA trial e...
